肺炎球菌疫苗时代儿童侵袭性肺炎球菌病中免疫缺陷的患病率:一项系统综述
该系统综述检索PubMed、Embase和MEDLINE,纳入报告微生物学确诊的原发性或复发性侵袭性肺炎球菌病(IPD)儿童免疫缺陷原创数据的文献。在6022例原发性IPD儿童中,免疫缺陷患病率从1.3%(5/393)至10.5%(17/162)不等,2岁以上儿童为26.4%(14/53),复发性IPD儿童高达66.7%(10/15)。抗体缺陷最常见,感染部位(脑膜炎或复杂性肺炎)与免疫缺陷风险相关。
要点
- 复发性IPD儿童免疫缺陷患病率高达66.7%,应转诊免疫评估。
- 2岁以上IPD儿童免疫缺陷患病率为26.4%,脑膜炎或复杂性肺炎风险最高。
- 抗体缺陷是最常见的免疫缺陷类型,其次为补体缺陷、无脾和T细胞信号缺陷。
核心结论
- 侵袭性肺炎球菌病尤其是复发性IPD是无其他危险因素儿童潜在原发性免疫缺陷的重要标志。
- 2岁以上患肺炎球菌脑膜炎或复杂性肺炎的儿童以及所有复发性IPD儿童应转诊进行免疫评估。
研究设计与样本
- 系统综述检索PubMed、Embase(1974年至2019年2月28日)和MEDLINE(1946年至2019年2月28日)。
- 纳入报告微生物学确诊的原发性或复发性IPD儿童免疫缺陷原创数据的文献,共6022例原发性IPD儿童。
- 临床数据强度按牛津循证医学中心5分制分级。
主要发现
- 在6022例原发性IPD儿童中,免疫缺陷患病率范围为1.3%(5/393)至10.5%(17/162)。
- 2岁以上原发性IPD儿童中免疫缺陷患病率为26.4%(14/53)。
- 复发性IPD儿童中免疫缺陷患病率高达66.7%(10/15)。
- 抗体缺陷是最常见的免疫缺陷,其次为补体缺陷、无脾和罕见的T细胞信号缺陷。
- 感染部位是潜在免疫缺陷风险的关键指标,脑膜炎或复杂性肺炎儿童风险最高。
关键数值与推荐
- 原发性IPD儿童免疫缺陷患病率:1.3%(5/393)至10.5%(17/162)。
- 2岁以上原发性IPD儿童免疫缺陷患病率:26.4%(14/53)。
- 复发性IPD儿童免疫缺陷患病率:高达66.7%(10/15)。
临床怎么用
- 对2岁以上患肺炎球菌脑膜炎或复杂性肺炎的儿童应转诊进行免疫评估。
- 对所有复发性IPD儿童应转诊进行免疫评估。
- 无其他危险因素的IPD儿童,尤其复发性IPD,应考虑潜在原发性免疫缺陷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite increasing access to vaccination, invasive pneumococcal disease (IPD) is responsible for approximately 826 000 deaths worldwide in children younger than 5 years each year. To allow early identification and prevention, an improved understanding of risk factors for IPD is needed. OBJECTIVES: To review the literature on the prevalence of primary immunodeficiency (PID) in children younger than 18 years presenting with IPD without another predisposing condition and to inform guidelines for immunologic evaluation after the first episode of IPD based on published evidence. EVIDENCE REVIEW: A literature search of PubMed, Embase (inception [1974] to February 28, 2019), and MEDLINE (inception [1946] to February 28, 2019) was conducted using the terms Streptococcus pneumonia, Streptococcus pneumoniae, pneumococcal infection, Streptococcus infection, pneumococcal meningitis, immunodeficiency, immune response, immunocompromised, susceptib*, precursor, predispose*, recurren*, newborn, neonat*, infan*, toddler, child, preschooler, adolescen*, and pediatric. Publications reporting original data on immunodeficiency in children with microbiologically confirmed primary or recurrent IPD were included. Strength of clinical data was graded according to the 5-point scale of the Oxford Centre for Evidence-Based Medicine. FINDINGS: In 6022 unique children with primary IPD, 5 of 393 (1.3%) to 17 of 162 (10.5%) of all children and 14 of 53 (26.4%) of those older than 2 years had a PID identified. Higher rates of PID, up to 10 of 15 (66.7%), were found in children with recurrent IPD. Antibody deficiency was the most common immunodeficiency, followed by complement deficiency, asplenia, and rarer defects in T-cell signaling. The site of infection was a key indicator for the risk of underlying PID, with the greatest risk of PID in children with meningitis or complicated pneumonia. CONCLUSIONS AND RELEVANCE: Results of this study suggest that invasive pneumococcal disease, and particularly recurrent IPD, is an important marker of underlying PID in children without other risk factors. The findings also suggest that children older than 2 years with pneumococcal meningitis or complicated pneumonia and all children with recurrent IPD should be referred for an immune evaluation. TRIAL REGISTRATION: PROSPERO identifier: CRD42017075978.
引用
- Butters C, Phuong LK, Cole T, et al. Prevalence of Immunodeficiency in Children With Invasive Pneumococcal Disease in the Pneumococcal Vaccine Era: A Systematic Review. JAMA Pediatr. 2019. PMID: 31566672. doi:10.1001/jamapediatrics.2019.3203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。